IbrutinibHepatitis B reactivation: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1827卷 / 1期

关键词：

D O I：

10.1007/s40278-020-84922-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：167 / 167

相关论文

共 50 条

[31] ZanubrutinibHepatitis B reactivation: case report
Reactions Weekly, 2018, 1706 (1) : 484 - 484
[32] TemozolomideFirst report of reactivation of hepatitis B: case report
Reactions Weekly, 2007, 1149 (1) : 24 - 24
[33] EtanerceptFirst report of hepatitis B reactivation: case report
Reactions Weekly, 2007, 1165 (1) : 12 - 12
[34] RituximabHepatitis B virus reactivation: case report
Reactions Weekly, 2018, 1706 (1) : 439 - 439
[35] OcrelizumabHepatitis B virus reactivation: case report
Reactions Weekly, 2019, 1745 (1) : 208 - 208
[36] Ledipasvir/sofosbuvirHepatitis B reactivation: case report
Reactions Weekly, 2018, 1712 (1) : 327 - 327
[37] PrednisoloneHepatitis B virus reactivation: case report
Reactions Weekly, 2023, 1946 (1) : 472 - 472
[38] RituximabHepatitis B virus reactivation: case report
Reactions Weekly, 2008, 1199 (1) : 40 - 40
[39] Everolimus/exemestaneHepatitis B reactivation: case report
Reactions Weekly, 2017, 1641 (1) : 124 - 124
[40] AntineoplasticsFatal hepatitis B reactivation: case report
Reactions Weekly, 2010, 1306 (1) : 10 - 10

← 1 2 3 4 5 →